A new watchdog for cancer care met for the first time today
What happened
On Monday 21 September 2026, the Department of Health and Social Care announced a new National Cancer Board for England. Its first meeting was held the same day. The board is a group of independent experts. Its job is to check whether the promises in the National Cancer Plan are actually being kept. The plan contains more than 100 commitments, covering things like how quickly people are diagnosed and how fast treatment starts. Anita Charlesworth is the independent co-chair. She leads the board alongside Mark Cubbon from NHS England and the Department of Health and Social Care. Three named leads will each watch a particular gap in care: Dr Rob Metcalf on rare cancers, Dr Dianne Addei on inequalities, and Ashley Ball-Gamble on cancers in children and young people. Professor Peter Johnson, the national clinical director for cancer at NHS England, is also part of the work. The board will meet four times a year. Every year it will publish an assessment of how things are going. Every three years it will carry out a deeper review. Where progress is too slow, it will say so and advise ministers on what to do about it.
Why this matters
Cancer reaches almost every family in some way. Anita Charlesworth put it plainly: "Half of us will be diagnosed with cancer during our lives, so this matters profoundly to patients and families." Plans are easy to write. Keeping them is the hard part. A ten-year plan can quietly drift, and by the time anyone notices, years have gone. The point of a board that publishes its findings in public is that slow progress becomes visible while there is still time to fix it. There is some progress to build on. According to government figures, around 250,000 more people over the last year were either diagnosed on time or had cancer ruled out, compared with the year before the election. Cancer Research UK, the largest cancer charity in the country, welcomed the move. Its chief executive, Michelle Mitchell, said: "Delivering lasting change for people affected by cancer will require strong leadership and clear accountability." That last word matters. Accountability means somebody has to answer for the result, not just announce the plan.
What the evidence actually says
It is worth being clear about what this announcement is, and what it is not. A board does not treat anybody. It does not shorten a waiting list on its own, buy a scanner, or hire a nurse. It is a group of people whose job is to look closely at the numbers and ask awkward questions. Whether that helps depends on what happens next. The figure of 250,000 is a government figure, and it is worth reading carefully. It counts people who were diagnosed on time or had cancer ruled out. That is a real improvement — being told quickly that you do not have cancer is a genuine relief, and finding it early usually leads to better treatment. But it is not the same as a measure of how many people survived. The plan's headline ambition is that, by 2035, three in four people diagnosed with cancer will be free of it or living well five years later. That is a goal, not a finding. Nothing published this week shows it has been reached. What is genuinely new is the structure. Meetings four times a year, a published assessment every year, a deeper review every three years, and named people responsible for rare cancers, for inequalities, and for children and young people. Those three areas are often where care slips furthest behind, because the numbers are smaller and easier to overlook. There are no results yet. The fair thing is to judge this board by what it publishes in a year's time.
Qurexa perspective
Cancer treatment usually brings a lot of medicines with it: anti-sickness tablets, painkillers, steroids, tablets to protect the stomach, and the usual prescriptions someone was already taking. Keeping on top of all of that is hard work, and it often lands on a partner, a son or a daughter. It is also hard at exactly the wrong moment. The days after chemotherapy are often the days when getting to a pharmacy feels impossible. Qurexa cannot speed up a scan or move anyone up a waiting list. What we can do is deliver prescriptions to the door across Lincolnshire, and help people keep track of when repeat medicines are due, so that one errand comes off the list in a difficult week. If you are looking after someone else's medicines as well as your own, that is worth knowing about.
Practical advice
None of this changes what you can do yourself, and what you can do yourself still matters most. Know the signs worth checking. The NHS lists symptoms that should be looked at: a new lump, a mole that changes shape or colour, bleeding that is not normal for you, a cough that lasts more than three weeks, losing weight without trying, and a change in your bowel habits that carries on for three weeks or more. Do not put it off to avoid being a nuisance. This is the most common reason people wait, and it is the worst one. Most people who get checked do not have cancer. Your GP would far rather see you and find nothing. Say yes to screening. If a bowel, breast or cervical screening invitation lands on your mat, use it. Screening is designed to find things before you would ever notice them. If you have been referred, ask what happens next. Ask when you should expect to hear, and who to ring if you do not. Write the answer down. Keep a short note of symptoms with dates. Two lines in your phone is enough. It helps a lot in a ten-minute appointment. Ask about a clinical nurse specialist. If you are already being treated, they are usually the person who can get you a straight answer fastest.
What to know
England has a new National Cancer Board. It met for the first time on 21 September 2026, it is co-chaired independently by Anita Charlesworth, and its job is to check that more than 100 promises in the National Cancer Plan are being kept. It will report publicly once a year. That is a reasonable thing to do, and worth watching. But it is a body that checks on progress, not a treatment. The measurable thing today is still the oldest advice there is: if something in your body has changed and stayed changed, get it looked at, and take up screening when you are invited. Sources: Department of Health and Social Care (GOV.UK), 'Expert team to drive improvements in cancer care', 21 September 2026, https://www.gov.uk/government/news/expert-team-to-drive-improvements-in-cancer-care; Department of Health and Social Care (GOV.UK), 'National Cancer Plan for England', https://www.gov.uk/government/publications/national-cancer-plan-for-england; NHS, 'Symptoms of cancer', https://www.nhs.uk/conditions/cancer/symptoms/ This article is for general information and does not replace advice from a doctor, pharmacist or other qualified healthcare professional.
Related articles
Six hours, not never: the ICU filter notice the MHRA issued today
The UK's medicines and devices regulator has issued a new safety notice to hospitals, and it is about timing. On 13 October 2026 the Medicines and Healthcare p…
Eight pages to a minister: what the data guardian says trust is worth
On 12 October 2026, the government published a letter about who should be trusted with NHS patient data. It was written by Dr Nicola Byrne, the National Data G…
Update: the tests came back, and it was not plague
This is a follow-up to a story we covered on 5 October, when nearly 200 people were being monitored after the death of a laboratory worker in Siberia. There has…